HEPATITIS B

This study looked at whether giving young children 2 doses of the hepatitis B vaccine works as well as the standard 3 doses. Over 400 children aged 2 to 18 months took part. Researchers measured immune protection and memory to see if a simpler schedule could be just as effective.

This study looked at the safety of the Hexaxim vaccine, which protects against diseases like hepatitis B and Haemophilus influenzae type b, in infants starting at 2 months old in South Korea. Over 700 babies received the vaccine as part of routine care, and researchers tracked an…

This study tested whether a double-dose hepatitis B vaccine (40 micrograms) works better than the standard dose (20 micrograms) in people with HIV who had not responded to previous hepatitis B vaccines. The trial included 178 participants and measured how many developed protectiv…

This early-stage study tested a new hepatitis B vaccine that includes an extra ingredient called AS37 to boost the immune system. It involved 122 healthy adults aged 18-45 who received two doses one month apart. The main goal was to check safety and how well the body responds to …

This study tested an oral drug called selgantolimod in 29 adults who have both chronic hepatitis B and HIV and have been on stable antiviral therapy for at least 5 years. The goal was to see if the drug is safe and can lower hepatitis B surface antigen (HBsAg) levels in the blood…

This study tested a new drug called ARO-HBV in healthy volunteers and people with chronic hepatitis B. The main goal was to check if the drug is safe and how the body processes it. A total of 114 people took part, and researchers monitored side effects and drug levels in the bloo…

This study tested a strategy of using rapid point-of-care tests to screen pregnant women for sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis during routine antenatal visits in Zimbabwe. Over 1,000 women participated to see if immediate testing and t…

This study tested whether giving pregnant women with hepatitis B a daily pill (tenofovir) plus a vaccine at birth can safely prevent passing the virus to their babies. Over 300 mothers in the Democratic Republic of Congo took part, and researchers tracked safety and how well the …

This study aimed to find out how many people held at the Nîmes administrative detention center have HIV, hepatitis B, or hepatitis C. Researchers used rapid tests to get results quickly, since many detainees leave before standard lab results come back. A total of 350 detainees to…

This study looked at how common hepatitis B and C are in African and Asian immigrants living in Minnesota, and how these infections might lead to liver cancer. Researchers tested 892 adults for hepatitis markers and tracked liver cancer cases over time. The goal was to better und…

This study looked at whether doctors followed guidelines to screen COVID-19 patients for hepatitis B before giving them steroids. Researchers tracked 1793 hospitalized adults to see if the virus reactivated. The goal was to understand risks and improve safety in a country with lo…

This study looked at 805 blood donors who tested positive for hepatitis C virus (HCV) to learn how the virus spreads, who gets sick, and what happens over time. Participants gave blood samples and answered questions about their health and lifestyle. The goal was to better underst…